Ranitidine-d6

CAS : 1185514-83-3

Ref. 3D-KXB51483

Informations sur le produit

• Nom: Ranitidine-d6
• Synonymes: 1,1-Ethenediamine, N-[2-[[[5-[[di(methyl-d3)amino]methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-, N-[2-[[[5-[[Di(methyl-d3)amino]methyl]-2-furanyl]methyl]thio]ethyl]-N′-methyl-2-nitro-1,1-ethenediamine

Description

Ranitidine is a drug that belongs to the class of histamine-2 receptor antagonists. It has been shown to inhibit the transport of synthetic cathinones, such as methylone, in wastewater samples. Ranitidine is also used to study the potential use of this drug in the treatment of carcinogenesis. Ranitidine-d6 is a radioactive form of ranitidine and can be used for research purposes. This drug is used for the diagnosis and imaging of tumors and other body organs by utilizing positron emission tomography (PET) scans.

Ranitidine-d6 can be used as a tracer in studies on cancer cell metabolism and tumor growth, as well as being able to differentiate between benign and malignant lesions in PET scans. The radiolabeled form of ranitidine-d6 can be used as an alternative to 18F-FDG, which is currently considered the gold standard in PET imaging, due to its low cost and availability.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 320.44 g/mol
• Formule: C₁₃H₂₂N₄O₃S
• Degré de pureté: Min. 95%